1 March 2023

BIOPHARMA CREDIT PLC

(the "Company") 

NOTICE OF FULL YEAR RESULTS

BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its audited Full Year Results for the period ending 31 December 2022 on Wednesday 22 March 2023.

A management presentation will be delivered at 9:30am GMT at the offices of Buchanan, 107 Cheapside, EC2V 6DN and through a webcast facility for those unable to attend in person. To register to attend or request details, RSVP to biopharmacredit@buchanan.uk.com.

-Ends-

 Enquiries

 BioPharma Credit PLC

via Link Company Matters Limited

Company Secretary

+44 (0) 1392 477 500

Buchanan

+44 (0)20 7466 5000

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

biopharmacredit@buchanan.uk.com

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24